Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients

Autori: Barbieri M, Rizzo MR, Fava I, Sardu C, Angelico N, Paolisso P, Abbatecola AM, Paolisso G, Marfella R

Data: 2016

Ambito di interesse: metabolismo, diabete

Rivista: J Diabetes Res

Potrebbero interessarti anche:

Rivista 7.14

Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.

Autori: Cerulli Irelli E, Morano A, Cocchi E, Casciato S, Fanella M, Albini M, Avorio F, Basili LM, Fisco G, Barone FA, Mascia A, D'Aniello A, Manfredi M, Fattouch J, Quarato P, Giallonardo AT, Di Gennaro G, Di Bonaventura C.

Data: 2019

Ambito di interesse: Epilessia

Rivista: Epilepsia. 2019 Dec 11

Leggi dettagli

Rivista 7,4

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Autori: ranieri r et al

Data: 17 apr 2023

Ambito di interesse: infettivologico/sanità penitenziaria

Rivista: Infection

Leggi dettagli

Rivista 5,1

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Autori: Benedetta Stefanini et al

Data: 22 nov 2023

Ambito di interesse: epatologico

Rivista: Dig Liver Dis

Leggi dettagli

Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients

Potrebbero interessarti anche:

Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome.

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

Cosa fare per